Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging

QR Code

Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging

Amyloid-β (Aβ) plays a central role in the pathogenesis of Alzheimer's disease (AD) and has been postulated as a potential biomarker for AD. However, there is a lack of consensus as to its suitability as an AD biomarker. The objective of this study was to determine the significance of plasma Aβ...

Full description

Bibliographic Details
Main Authors:	Lui, J., Laws, S., Li, Q., Villemagne, V., Ames, D., Brown, B., Bush, A., De Ruyck, K., Dromey, J., Ellis, K., Faux, N., Foster, Jonathan, Fowlor, C., Gupta, V., Hudson, P., Laughton, K., Masters, C., Pertile, K., Rembach, A., Rimajova, M., Rodrigues, M., Rowe, C., Rumble, R., Szoeke, C., Taddei, K., Taddei, T., Trounson, B., Ward, V., Martins, R.
Format:	Journal Article
Published:	IOS Press 2010
Online Access:	http://hdl.handle.net/20.500.11937/31314

Similar Items

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011)

Longitudinal cognitive decline in the AIBL cohort: The role of APOE e4 status
by: Albrecht, Matthew, et al.
Published: (2015)

Longitudinal cognitive decline in the AIBL cohort: the role of APOE ε4 status
by: Foster, J., et al.
Published: (2014)

Associations between gonadotropins, testosterone and [beta] amyloid in men at risk of Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2014)

Effects of anticholinergic drugs on cognitive function in older Austalians: Results from the AIBL study
by: Sittironnarit, G., et al.
Published: (2011)

Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies
by: Martins, R., et al.
Published: (2018)

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer’s disease
by: Ellis, K., et al.
Published: (2009)

Impact of Mild Head Injury on Neuropsychological Performance in Healthy Older Adults: Longitudinal Assessment in the AIBL Cohort
by: Albrecht, Matthew, et al.
Published: (2016)

KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aß-amyloid burden
by: Porter, T., et al.
Published: (2018)

Amyloid ß–associated cognitive decline in the absence of clinical disease progression and systemic illness
by: Harrington, K., et al.
Published: (2017)

ß-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men
by: Holmes, S., et al.
Published: (2016)

Distinct Effects of Testosterone on Plasma and Cerebrospinal Fluid Amyloid-ß Levels
by: Wahjoepramono, E., et al.
Published: (2008)

A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease
by: Porter, T., et al.
Published: (2018)

Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
by: Burnham, S., et al.
Published: (2016)

Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study
by: Holmes, S., et al.
Published: (2018)

Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests
by: Bates, K., et al.
Published: (2009)

Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity
by: Taddei, K., et al.
Published: (2010)

Testosterone replacement therapy in older male subjective memory complainers: Double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety
by: Asih, P., et al.
Published: (2015)

BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF
by: Lim, Y., et al.
Published: (2017)

Erratum: Clearance mechanisms of Alzheimer's amyloid-? peptide: Implications for therapeutic design and diagnostic tests (Molecular Psychiatry (2009) 14 (469-486) DOI: 10.1038/mp.2008.96)
by: Bates, K., et al.
Published: (2009)

Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner
by: Gardener, S., et al.
Published: (2017)

Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels
by: Wahjoepramono, E., et al.
Published: (2011)

Klotho allele status is not associated with Aß and APOE e4–related cognitive decline in preclinical Alzheimer's disease
by: Porter, T., et al.
Published: (2019)

Effect of chronic hCG administration on Alzheimer's-related cognition and Aß accumulation in PS1KI mice
by: Barron, A., et al.
Published: (2010)

Validation and characterisation of a novel peptide that binds monomeric and aggregated beta-amyloid and inhibits the formation of neurotoxic oligomers
by: Barr, R., et al.
Published: (2015)

Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study
by: Foster, Jonathan, et al.
Published: (2013)

Cerebral glucose metabolism is associated with verbal not visual performance in community-dwelling older adults
by: Gardner, S., et al.
Published: (2016)

Cerebral amyloid-ß accumulation and deposition following traumatic brain injury-A narrative review and meta-analysis of animal studies
by: Bird, S., et al.
Published: (2016)

Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
by: Porter, T., et al.
Published: (2018)

Design and construction of wideband VNA ground-based radar system with real and synthetic aperture measurement capabilities
by: Lim, K. -S., et al.
Published: (2008)

Accurate and reliable diagnosis and classification using probabilistic ensemble simplified fuzzy ARTMAP
by: Loo, C.K., et al.
Published: (2005)

APOE e4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals: A cross-sectional observational study
by: Cysique, L., et al.
Published: (2015)

Design, simulation and measurement of a post slot waveguide antenna
by: Lim, K.-S., et al.
Published: (2007)

Process Modelling, Thermodynamic Analysis and Optimization of Dry Reforming, Partial Oxidation and Auto-Thermal Methane Reforming for Hydrogen and Syngas Production
by: Ayodele, Bamidele V., et al.
Published: (2015)

Biorefinery for the Production of Biodiesel, Hydrogen and Synthesis Gas Integrated with CHP from Oil Palm in Malaysia
by: Ayodele, Bamidele V., et al.
Published: (2016)

Modelling and Optimization of Syngas Production from Methane Dry Reforming Over Ceria-Supported Cobalt Catalyst Using Artificial Neural Networks and Box–Behnken Design
by: Ayodele, Bamidele V., et al.
Published: (2015)

<I>i</I>Sim — An Integrated Sar Product Simulator for System Designers and Researchers
by: Koo, V. C., et al.
Published: (2007)

The Relationship Between Memory Complaints, Perceived Quality of Life and Mental Health in Apolipoprotein E epsilon 4 Carriers and Non-Carriers
by: Sohrabi, H.R., et al.
Published: (2009)

Association of Cardiovascular Factors and Alzheimer's Disease Plasma Amyloid-beta Protein in Subjective Memory Complainers
by: bates, K., et al.
Published: (2009)

The dynamics of CD147 in Alzheimer's disease development and pathology
by: Kanyenda, L., et al.
Published: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hv23ao7i430l387sd1k6prt8io